Insights / Latest News

And How a Growing Global Feasibility Network Changes That Clinical trials rarely fail because of science. They fail because of unrealistic feasibility assumptions. Overestimated recruitment. Under performing sites. Delayed activation. Amendments that drain budgets. And every month lost is lost patent lifetime. The Real Risk: Poor Site Selection Sponsors and CROs still rely heavily on: Historical relationships Email-based feasibility surveys Self-reported recruitment optimism